NCT06671015View on ClinicalTrials.gov

A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Systolic Heart FailureRespiratory Failure

Interventions

DEVICE

Airvo 3

Provides effective therapy for acute hypoxemic respiratory failure and post-extubation respiratory support for 24 hours post-extubation.

Trial Locations (1)

06520

Yale New Haven Hospital (CICU or MICU), New Haven

All Listed Sponsors

collaborator

Fisher & Paykel Healthcare Limited

UNKNOWN

lead

Yale University

OTHER

NCT06671015 - A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure | Biotech Hunter | Biotech Hunter